Study of treatments and outcomes for primary skin lymphoma
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study looks at what treatments work for people with primary cutaneous lymphoma, and how patients do over time. It uses real patient information from participating hospitals to understand outcomes after diagnosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were evaluated at a participating medical center in the study
- Your skin biopsy confirmed primary cutaneous lymphoma (a pathologist diagnosis)
- You can provide informed consent (agree to take part)
- You can complete the study questionnaires on your own, or with help from the study team
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at skin lymphomas (a type of white blood cell cancer that starts in the skin) to find factors that predict how the disease will progress and to identify new ways to treat it. By joining, you help researchers understand and improve treatment for this condition.
This study follows people with primary cutaneous T-cell lymphoma who are seen at the Dermatology Unit in Pavia. It collects information to better understand the disease and improve care.
This study aims to understand how common skin lymphomas are in Italy. You might be able to help if you have been diagnosed with a skin lymphoma.
This study looks at the bacteria (microbiome) living on the skin in people with specific skin conditions, and in healthy volunteers. The results may help researchers understand what skin microbes have to do with these diseases.
This study asks people with cutaneous lymphoma to fill out a questionnaire about quality of life. The goal is to better understand how this illness affects day-to-day life and comfort.
This study collects stored tissue samples (from skin or other needed procedures) from people with CTCL, Sézary syndrome, or lymphomatoid papulosis, especially when you are starting or changing treatment. It’s meant to help researchers learn more about these illnesses and may support future research.
Hear when a new Primary Cutaneous Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.